Research review of fatigue recognition and management in patients with interstitial lung disease

doi:10.3761/j.issn.0254-1769.2023.15.005

Abstract

Abstract:

Fatigue is one of the most common complaints in patients with interstitial lung disease（ILD） and seriously affects their prognosis and quality of survival. The study introduces the hazards of fatigue in patients with interstitial lung disease，and describes the common measurement tools for fatigue symptoms in ILD. Management measures to improve their symptoms are summarized in order to provide a basis for the development of comprehensive，multidisciplinary and individualized ILD fatigue management programs in the clinical settings.

Key words: Interstitial Lung Disease, Fatigue, Symptom Management, Review, Nursing Care

摘要：

疲劳是间质性肺疾病患者最常见的主诉之一，严重影响患者的预后及生存质量。该文介绍了间质性肺疾病患者疲劳的危害、疲劳的评估工具，并对非药物干预措施进行总结，包括运动训练、无创通气、认知行为疗法、营养支持，以期为加强临床护理人员对间质性肺疾病患者的疲劳管理意识，制订间质性肺疾病疲劳管理方案提供参考。

关键词: 间质性肺疾病, 疲劳, 症状管理, 综述, 护理

SHANG Yameng, LIU Fangli, LI Jiaxin, LIU Ziwei, WANG Yingying, LI Yuege, XI Fang. Research review of fatigue recognition and management in patients with interstitial lung disease[J]. Chinese Journal of Nursing, 2023, 58(15): 1821-1825.

尚娅萌, 刘芳丽, 李佳欣, 刘子薇, 王莹莹, 栗跃歌, 席芳. 间质性肺疾病患者疲劳管理的研究进展[J]. 中华护理杂志, 2023, 58(15): 1821-1825.

References 44

[1]	Kahlmann V, Moor CC, Wijsenbeek MS. Managing fatigue in patients with interstitial lung disease[J]. Chest, 2020, 18(5):2026-2033.
[2]	Bahmer T, Watz H, Develaska M, et al. Physical activity and fatigue in patients with sarcoidosis[J]. Respiration, 2018, 95(1):18-26. DOI PMID
[3]	Guenther A, Krauss E, Tello S, et al. The European IPF registry(eurIPFreg):baseline characteristics and survival of patients with idiopathic pulmonary fibrosis[J]. Respir Res, 2018, 19(1):141. DOI
[4]	侯晓洁, 傅荣, 高莉, 等. 间质性肺疾病患者疲乏影响因素及非药物干预研究进展[J]. 护理学杂志, 2022, 37(3):104-108.
	Hou XJ, Fu R, Gao L, et al. A review of factors affecting fatigue in patients with interstitial lung disease and the non-pharmacologic interventions[J]. J Nurs Sci, 2022, 37(3):104-108.
[5]	Dowman L, HillC J, May A, et al. Pulmonary rehabilitation for interstitial lung disease[J]. Cochrane Database Syst Rev, 2021, 2(2):CD006322.
[6]	梁发存, 刘梦如, 尹艳茹, 等. 慢性阻塞性肺疾病患者运动恐惧的调查研究[J]. 中华护理杂志, 2023, 58(6):721-726. DOI URL
	Liang FC, Liu MR, Yin YR, et al. Investigation on the develop-ment trajectories of exercise fear in patients with chronic ob-structive pulmonary disease[J]. Chin J Nurs, 2023, 58(6):721-726.
[7]	Saketkoo LA, Russell AM, Jensen K, et al. Health-related quali-ty of life(HRQoL) in sarcoidosis:diagnosis,management,and health outcomes[J]. Diagnostics(Basel), 2021, 11(6):1089.
[8]	Marcellis RG, Lenssen AF, Elfferich MD, et al. Exercise capacity,muscle strength and fatigue in sarcoidosis[J]. Eur Respir J, 2011, 38(3):628-634. DOI PMID
[9]	Voortman M, de Vries J, Hendriks CMR, et al. Everyday cognitive failure in patients suffering from neurosarcoidosis[J]. Sarcoidosis Vasc Diffuse Lung Dis, 2019, 36(1):2-10.
[10]	Pilzak K, Żebrowska A, Sikora M, et al. Physical functioning and symptoms of chronic fatigue in sarcoidosis patients[J]. Adv Exp Med Biol, 2018, 1040:13-21. DOI PMID
[11]	Aronson KI, Danoff SK, Russell AM, et al. Patient-centered outcomes research in interstitial lung disease:an official American thoracic society research statement[J]. Am J Respir Crit Care Med, 2021, 204(2):e3-e23. DOI URL
[12]	de Kleijn WP, Drent M, De Vries J. Nature of fatigue moderates depressive symptoms and anxiety in sarcoidosis[J]. Br J Health Psychol, 2013, 18(2):439-52. DOI PMID
[13]	Arkema EV, Eklund A, Grunewald J, et al. Work ability before and after sarcoidosis diagnosis in Sweden[J]. Respir Med, 2018, 144:s7-s12. DOI URL
[14]	Hendriks CMR, Saketkoo LA, Elfferich MDP, et al. Sarcoidosis and work participation:the need to develop a disease-specific core set for assessment of work ability[J]. Lung, 2019, 197(4):407-413. DOI PMID
[15]	Michielsen HJ, de Vries J, van Heck GL. Psychometric qualities of a brief self-rated fatigue measure:The Fatigue Assessment Scale[J]. J Psychosom Res, 2003, 54(4):345-352. DOI PMID
[16]	Hendriks C, Drent M, Elfferich M, et al. The Fatigue Assessment Scale:quality and availability in sarcoidosis and other diseases[J]. Curr Opin Pulm Med, 2018, 24(5):495-503. DOI PMID
[17]	de Vries J, Michielsen H, Van Heck GL, et al. Measuring fatigue in sarcoidosis:the Fatigue Assessment Scale(FAS)[J]. Br J Health Psychol, 2004, 9(3):279-291. DOI URL
[18]	Ho LYW, Lai CKY, Ng SSM. Measuring fatigue following stroke:the Chinese version of the Fatigue Assessment Scale[J]. Disabil Rehabil, 2021, 43(22):3234-3241. DOI URL
[19]	Krupp LB, Larocca NG, Muir-Nash J, et al. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus[J]. Arch Neurol, 1989, 46(10):1121-1123. DOI URL
[20]	Dowman LM, May AK, Hill CJ, et al. High intensity interval training versus moderate intensity continuous training for people with interstitial lung disease:protocol for a randomised controlled trial[J]. BMC Pulm Med, 2021, 21(1):361. DOI PMID
[21]	吴春薇, 王得新. 疲劳严重度量表中译本应用于脑梗死患者的临床与评价[J]. 中华物理医学与康复杂志, 2007, 29(9):608-611.
	Wu CW, Wang DX. Clinical application and assessment of the Chinese version of Fatigue Severity Scale in stroke patients[J]. Chin J Rehabil Med, 2007, 29(9):608-611.
[22]	Smets EM, Garssen B, Bonke B, et al. The Multidimensional Fatigue Inventory(MFI) psychometric qualities of an instrument to assess fatigue[J]. J Psychosom Res, 1995, 39(3):315-325. DOI PMID
[23]	Chuang LL, Chuang YF, Hsu MJ, et al. Validity and reliability of the Traditional Chinese version of the Multidimensional Fatigue Inventory in general population[J]. PLoS One, 2018, 13(5):e0189850.
[24]	潘瑞丽, 杨慧, 徐颖臻. 间质性肺疾病病人疲乏现状及影响因素[J]. 护理研究, 2019, 33(17):3091-3094.
	Pan RL, Yang H, Xu YZ. Status quo and influencing factors of fatigue in patients with interstitial lung disease[J]. Chin Nurs Res, 2019, 33(17):3091-3094.
[25]	韩秋凤, 田俊. 多维疲劳量表应用于肿瘤患者的信度和效度验证[J]. 中华护理杂志, 2012, 47(6):548-550.
	Han QF, Tian J. The relability and validity of the Multidimensional Fatigue lnventory-20 in cancer patients[J]. Chin J Nurs, 2012, 47(6):548-550.
[26]	龚莉, 林茜, 董铭琦, 等. 急性心肌梗死患者疲劳发展轨迹的调查研究[J]. 中华护理杂志, 2022, 57(2):176-181. DOI URL
	Gong L, Lin Q, Dong MQ, et al. The investigation of fatique development trajectory in patients with acute myocardial infarctionl[J]. Chin J Nurs, 2022, 57(2):176-181.
[27]	Lee KA, Hicks G, Nino-Murcia G. Validity and reliability of a scale to assess fatigue[J]. Psychiatry Res, 1991, 36(3):291-298. DOI URL
[28]	Moor CC, Mostard RL M, Grutters JC, et al. The use of online visual analogue scales in idiopathic pulmonary fibrosis[J]. Eur Respir J, 2022, 59(1):2101531.
[29]	陈泯竹, 江智霞, 王雨, 等. Lee版疲劳视觉模拟量表汉化及在急性胰腺炎患者中的信效度检验[J]. 中华现代护理杂志, 2021, 27(16):2113-2119.
	Chen MZ, Jiang ZX, Wang Y, et al. The Chinese version of Lee’s Visual Analogue Scale for Fatigue and its reliability and validity in patients with acute pancreatitis[J]. Chin J Mod Nurs, 2021, 27(16):2113-2119.
[30]	Guber E, Wand O, Epstein Shochet G, et al. The short-and long-term impact of pulmonary rehabilitation in subjects with sarcoidosis:a prospective study and review of the literature[J]. Respiration, 2021, 100(5):423-431. DOI URL
[31]	Sanchez-Ramirez DC. Impact of pulmonary rehabilitation services in patients with different lung diseases[J]. J Clin Med, 2022, 11(2):407. DOI URL
[32]	陆海晴, 程洁. 基于区域肺部疾病护理联盟实施延续护理方案对间质性肺疾病患者干预效果的研究[J]. 中华护理杂志, 2018, 53(10):1179-1185.
	Lu HQ, Cheng J. The intervention effects of transitional care model in patients with interstitial lung disease based on regional lung disease nursing alliance[J]. Chin J Nurs, 2018, 53(10):1179-1185.
[33]	Amin R, Maiya GA, Mohapatra AK, et al. Effect of a home-based pulmonary rehabilitation program on functional capacity and health-related quality of life in people with interstitial lung disease:a randomized controlled trial protocol[J]. Respir Med, 2022, 201:106927. DOI URL
[34]	Drent M, Elfferich M, Breedveld E, et al. Benefit of wearing an activity tracker in sarcoidosis[J]. J Pers Med, 2020, 10(3):97. DOI URL
[35]	Dreher M, Ekkernkamp E, Schmoor C, et al. Pulmonary rehabilitation and noninvasive ventilation in patients with hypercapnic interstitial lung disease[J]. Respiration, 2015, 89(3):208-213. DOI PMID
[36]	Mari PV, Pasciuto G, Siciliano M, et al. Obstructive sleep apnea in sarcoidosis and impact of CPAP treatment on fatigue[J]. Sarcoidosis Vasc Diffuse Lung Dis, 2020, 37(2):169-178.
[37]	Papadogiannis G, Bouloukaki I, Mermigkis C, et al. Patients with idiopathic pulmonary fibrosis with and without obstructive sleep apnea:differences in clinical characteristics,clinical outcomes,and the effect of PAP treatment[J]. J Clin Sleep Med, 2021, 17(3):533-544. DOI PMID
[38]	Bloem AEM, Mostard RLM, Stoot N, et al. Perceptions of fatigue in patients with idiopathic pulmonary fibrosis or sarcoidosis[J]. J Thorac Dis, 2021, 13(8):4872-4884. DOI PMID
[39]	Kahlmann V, Moor CC, Van Helmondt SJ, et al. Online mindfulness-based cognitive therapy for fatigue in patients with sarcoidosis(TIRED):a randomised controlled trial[J]. Lancet Respir Med, 2022,S2213-2600(22):00387-3.
[40]	Saketkoo LA, Karpinski A, Young J, et al. Feasibility,utility and symptom impact of modified mindfulness training in sarcoidosis[J]. ERJ Open Res, 2018, 4(2):00085-2017.
[41]	Arosio B, Cesari M. Nutrition and muscle health[J]. Nutrients, 2021, 13(3):797. DOI URL
[42]	励建安. 呼吸康复视野的拓展[J]. 中国康复医学杂志, 2022, 37(2):145-147.
	Li JA. The extension of vision of respiratory rehabilitation[J]. Chin J Rehabil Med, 2022, 37(2):145-147.
[43]	Kushima H, Kinoshita Y, Fujita M, et al. A retrospective study on the efficacy of Ninjin’yoeito on fatigue in patients with interstitial pneumonia[J]. Neuropeptides, 2021, 89:102178. DOI URL
[44]	Galluzzo V, Zazzara MB, Ciciarello F, et al. Fatigue in COVID-19 survivors:the potential impact of a nutritional supplement on muscle strength and function[J]. Clin Nutr ESPEN, 2022, 51:215-221. DOI URL